MicroTech Medical (Hangzhou) Co (HKSE:02235) ROCE % : -9.96% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroTech Medical (Hangzhou) Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. MicroTech Medical (Hangzhou) Co's annualized ROCE % for the quarter that ended in Dec. 2023 was -9.96%.

MicroTech Medical (Hangzhou) Co ROCE % Historical Data

The historical data trend for MicroTech Medical (Hangzhou) Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroTech Medical (Hangzhou) Co ROCE % Chart

MicroTech Medical (Hangzhou) Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-36.12

-25.95

-3.26

-1.49

-5.77

MicroTech Medical (Hangzhou) Co Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial			-2.59	-0.69	-2.37	-1.67	-9.96

MicroTech Medical (Hangzhou) Co ROCE % Calculation

MicroTech Medical (Hangzhou) Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-136.503	/	( ( (2561.852 - 88.397)	+	(2361.23 - 102.136) )	/ 2 )
	=	-136.503	/	( (2473.455	+	2259.094)	/ 2 )
	=	-136.503	/	2366.2745
	=	-5.77 %

MicroTech Medical (Hangzhou) Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-232.266	/	( ( (2476.092 - 73.248)	+	(2361.23 - 102.136) )	/ 2 )
	=	-232.266	/	( ( 2402.844	+	2259.094 )	/ 2 )
	=	-232.266	/	2330.969
	=	-9.96 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

MicroTech Medical (Hangzhou) Co (HKSE:02235) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

MicroTech Medical (Hangzhou) Co ROCE % Related Terms

Thank you for viewing the detailed overview of MicroTech Medical (Hangzhou) Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroTech Medical (Hangzhou) Co Ltd (HKSE:02235) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 108 Liuze Street, Cangqian Street, Yuhang District, Zhejiang Province, Hangzhou, CHN

Website

https://www.microtechmd.com

MicroTech Medical (Hangzhou) Co Ltd is engaged in the research and development and manufacturing and commercialization of diabetes management, providing both diabetes treatment and diabetes monitoring medical devices to improve diabetes management in China and the rest of the world. The company derives a majority of its revenue from China.

MicroTech Medical (Hangzhou) Co (HKSE:02235) Headlines

No Headlines